The β-thalassemiasOLIVIERI, N. F.The New England journal of medicine. 1999, Vol 341, Num 2, pp 99-109, issn 0028-4793Article

MOVIMENTO PARADOSSO DEL SETTO INTERVENTRICOLARE ED EAS IN UN CASO DI CARDIOPATA CONGENITA COMPLESSA DELL' ADULTO A PREVALENTE SEVRACCARICO DI PRESSIONE DEL VENTRICOLO DESTRO = MOUVEMENT PARADOXAL DE LA CLOISON INTERVENTRICULAIRE ET DEVIATION GAUCHE DE L'AXE DANS UN CAS DE CARDIOPATHIE CONGENITALE COMPLEXE DE L'ADULTE AVEC SURCHARGE PREDOMINANTE DE PRESSION DU VENTRICULE DROITD'ANNUNZIO E; MOBILIJ A; OLIVIERI N et al.1982; MINERVA MED.; ISSN 0026-4806; ITA; DA. 1982; VOL. 73; NO 14; PP. 817-820; ABS. ENG; BIBL. 4 REF.Article

SINCOPE IN RAPPORTO AD IPERREFLESSIVITA DEL SENO CAROTIDEO: CONTRIBUTO PERSONALE = SYNCOPES EN RAPPORT AVEC UNE HYPERREFLEXIVITE DU SINUS CAROTIDIEN. CONTRIBUTION PERSONNELLED'ANNUNZIO E; MOBILIJ A; OLIVIERI N et al.1977; BOLL. SOC. ITAL. CARDIOL.; ITA; DA. 1977 PUBL. 1979; VOL. 22; NO 12; PP. 2342-2348; ABS. ENG; BIBL. 15 REF.Article

Reactivation of fetal hemoglobin in patients with β-thalassemiaOLIVIERI, N. F.Seminars in hematology. 1996, Vol 33, Num 1, pp 24-42, issn 0037-1963Article

Iron overload cardiomyopathies : new insights into an old diseaseLIU, P; OLIVIERI, N.Cardiovascular drugs and therapy. 1994, Vol 8, Num 1, pp 101-110, issn 0920-3206Article

Thalassaemia : clinical managementOLIVIERI, N.Baillière's clinical haematology. 1998, Vol 11, Num 1, pp 147-162, issn 0950-3536Article

Long-term therapy with deferiproneOLIVIERI, N. F.Acta haematologica. 1996, Vol 95, Num 1, pp 37-48, issn 0001-5792Article

Orally active iron chelatorsMERSON, L; OLIVIERI, N.Blood reviews. 2002, Vol 16, Num 2, pp 127-134, issn 0268-960XArticle

The therapeutic reactivation of fetal haemoglobinOLIVIERI, N. F; WEATHERALL, D. J.Human molecular genetics (Print). 1998, Vol 7, Num 10, pp 1655-1658, issn 0964-6906Article

Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in β thalassaemiaSAXON, B. R; REES, D; OLIVIERI, N. F et al.British journal of haematology. 1998, Vol 101, Num 3, pp 416-419, issn 0007-1048Article

Hydroxyurea in children with sickle cell disease : Impact on splenic function and compliance with therapyOLIVIERI, N. F; VICHINSKY, E. P.Journal of pediatric hematology/oncology. 1998, Vol 20, Num 1, pp 26-31, issn 1077-4114Article

Iron-chelating therapy and the treatment of thalassemiaOLIVIERI, N. F; BRITTENHAM, G. M.Blood. 1997, Vol 89, Num 3, pp 739-761, issn 0006-4971Article

Characterization of Fe²⁺ and Fe³⁺ transport by iron-loaded cardiac myocytesPARKES, J. G; OLIVIERI, N. F; TEMPLETON, D. M et al.Toxicology (Amsterdam). 1997, Vol 117, Num 2-3, pp 141-151, issn 0300-483XArticle

Detection of β-thalassemia using an artificial-restriction fragment length polymorphism generated by the polymerase chain reactionWARD, M. A; OLIVIERI, N. F; RODER, J. C et al.Nucleic acids research. 1991, Vol 19, Num 4, issn 0305-1048, p. 959Article

Compliance assessed by the medication event monitoring systemOLIVIERI, N. F; MATSUI, D; HERMANN, C et al.Archives of disease in childhood. 1991, Vol 66, Num 12, pp 1399-1402, issn 0003-9888Article

Use of a eutectic mixture of local anesthetics for prolonged subcutaneous drug administrationBERKOVITCH, M; DAVIS, S; MATSUI, D et al.Journal of clinical pharmacology. 1995, Vol 35, Num 3, pp 295-297, issn 0091-2700Article

Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular ironRANDELL, E. W; PARKES, J. G; OLIVIERI, N. F et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 23, pp 16046-16053, issn 0021-9258Article

Clinical use of the medication event monitoring system : a new window into pediatric complianceMATSUI, D; HERMANN, C; BRAUDO, M et al.Clinical pharmacology and therapeutics. 1992, Vol 52, Num 1, pp 102-103, issn 0009-9236Article

A high-performance liquid chromatographic method for the measurement of the iron chelator 1,2-dimethyl-3-hydroxypyridin-4-one in human plasmaKLEIN, J; DAMANI, L. A; CHUNG, D et al.Therapeutic drug monitoring. 1991, Vol 13, Num 1, pp 51-54, issn 0163-4356, 4 p.Article

Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell diseaseBERKOVITCH, M; PAPADOURIS, D; SHAW, D et al.British journal of clinical pharmacology. 1998, Vol 45, Num 6, pp 605-607, issn 0306-5251Article

The pharmacokinetics and pharmacodynamics of the oral iron chelator deferiprone (L1) in relation to hemoglobin levelsFASSOS, F. F; KLEIN, J; FERNANDES, D et al.International journal of clinical pharmacology and therapeutics. 1996, Vol 34, Num 7, pp 288-292, issn 0946-1965Article

Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelatorMATSUI, D; HERMANN, C; KLEIN, J et al.Journal of clinical pharmacology. 1994, Vol 34, Num 9, pp 944-949, issn 0091-2700Article

Urinary iron excretion depends on the mode of administration of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with homozygous β-thalassemiaFASSOS, F. F; KLEIN, J; FERNANDES, D et al.Clinical pharmacology and therapeutics. 1994, Vol 55, Num 1, pp 70-75, issn 0009-9236Article

Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cellsPARKES, J. G; HUSSAIN, R. A; OLIVIERI, N. F et al.The Journal of laboratory and clinical medicine. 1993, Vol 122, Num 1, pp 36-47, issn 0022-2143Article

Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicityBENTUR, Y; KOREN, G; TESORO, A et al.Clinical pharmacology and therapeutics. 1990, Vol 47, Num 4, pp 478-482, issn 0009-9236Conference Paper